CVS Stock Is Soaring. A Director Bets $2 Million on the Rally.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
MarketWatch on MSN10d
CVS’s stock is having its best day since 1999, after more than just earnings
CVS is a PBM through its CVS Caremark business. Tomi Kilgore is MarketWatch's deputy investing and corporate news editor and ...
CNBC on MSN14d
CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain. Joyner succeeded Karen Lynch in mid-October, as CVS struggled to drive ...
Hosted on MSN2mon
CVS accused of billing the U.S. for illegal opioid prescriptions
The DOJ accuses CVS of filling illegal opioid prescriptions ... That’ll do it for your Daily Briefing. From the New York Stock Exchange, I’m Conway Gittens with TheStreet.
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More
CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health Care Benefits and ...